Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

392.79 +2.49 (+0.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
64 65 Next >
This Is What Whales Are Betting On Vertex Pharmaceuticals
 
Via Benzinga
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move
Great companies haven't gone anywhere. 
Via The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
If you're looking for growth, these stocks could be just the ticket. 
Via The Motley Fool
Meta Stock Leads 5 Names Showing Resilience In Market Downturn
These stocks have held up so far, but patience is key amid the correction. 
Via Investor's Business Daily
Price Over Earnings Overview: Vertex Pharmaceuticals
 
Via Benzinga
2 Healthcare Stocks That Could Make You Richer
They've beaten the market before. 
Via The Motley Fool
Is NASDAQ:VRTX suited for quality investing?
Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX). 
Via Chartmill
Could These Be Vertex Pharmaceuticals' Most Promising Candidates?
The biotech has no shortage of promising pipeline programs. 
Via The Motley Fool
Expert Ratings for Vertex Pharmaceuticals
 
Via Benzinga
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years
These stocks are great long-term picks. 
Via The Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
The company hasn't performed well in the past five years, but things could change. 
Via The Motley Fool
2 Top Trends to Invest $500 In Right Now
Early investors in these trends may reap the rewards over time. 
Via The Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
There's no guarantee that any stock will be a millionaire-maker. But the chances for this one look pretty good. 
Via The Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
Catalysts on the horizon could drive gains in these top stocks. 
Via The Motley Fool
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
The returns are impressive, but will they continue to be so? 
Via The Motley Fool
Looking Into Vertex Pharmaceuticals's Recent Short Interest
 
Via Benzinga
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
 
Via Benzinga
Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor for Children With Cystic Fibrosis Ages 2 Through 5
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions. 
Via Investor's Business Daily
3 Top Healthcare Stocks Defying the Bear Market
Revenue at all three companies improved last quarter, and their share prices have followed suit. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Vertex Researchers Awarded 2024 Breakthrough Prize in Life Sciences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Better Bull Market Buy: CRISPR vs. Medtronic Stock
Investors may look for growth stocks ahead of the next bull market. 
Via The Motley Fool
A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later
These stocks should be even bigger winners than they already are when a new bull market takes hold. 
Via The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
These healthcare stocks show no signs of slowing down. 
Via The Motley Fool
1 Top Pharma Growth Stock to Buy Today and Hold Forever
Vertex's encouraging mix of recurring revenue and growth make it a leader. 
Via The Motley Fool
2 Top Biotech Stocks to Buy in September
There is rarely a bad time to buy stocks with massive upside potential. 
Via The Motley Fool
September Rally? 3 Stocks to Buy Before Liftoff
September has the reputation as the worst performing month of the year, but these are stocks to buy now in anticipation of the rally to come. 
Via InvestorPlace
3 Must-Know Tricks for Investing in Big Pharma Stocks
Using these tricks will help you appreciate where and when to invest. 
Via The Motley Fool
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock. 
Via InvestorPlace
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.